Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Central Pharmaceutical No3 Yönetim

Yönetim kriter kontrolleri 0/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	no data
CEO sahipliği	n/a
Yönetim ortalama görev süresi	Veri yok
Yönetim Kurulu ortalama görev süresi	Veri yok

Son yönetim güncellemeleri

Recent updates

CEO

Central Pharmaceutical No3 CEO'su yok ya da onlar hakkında elimizde veri yok.

Central Pharmaceutical No3 Yönetim

Yönetim kriter kontrolleri 0/4

Anahtar bilgiler

Son yönetim güncellemeleri

No independent directors

No independent directors

Recent updates

Second quarter 2024 earnings released: EPS: ₫1,290 (vs ₫1,470 in 2Q 2023)

Investor sentiment improves as stock rises 16%

First quarter 2024 earnings released: EPS: ₫1,025 (vs ₫1,071 in 1Q 2023)

Full year 2023 earnings released: EPS: ₫5,826 (vs ₫4,808 in FY 2022)

Upcoming dividend of ₫3,000 per share

Now 20% undervalued after recent price drop

Third quarter 2023 earnings released: EPS: ₫878 (vs ₫758 in 3Q 2022)

Second quarter 2023 earnings released: EPS: ₫3,676 (vs ₫1,378 in 2Q 2022)

Investor sentiment improves as stock rises 23%

Investor sentiment improves as stock rises 25%

Investor sentiment improves as stock rises 18%

First quarter 2023 earnings released: EPS: ₫2,677 (vs ₫3,011 in 1Q 2022)

Upcoming dividend of ₫8,000 per share at 5.8% yield

Investor sentiment improves as stock rises 17%

Full year 2022 earnings released: EPS: ₫12,654 (vs ₫10,966 in FY 2021)

No independent directors

Third quarter 2022 earnings released: EPS: ₫1,894 (vs ₫2,638 in 3Q 2021)

Second quarter 2022 earnings released: EPS: ₫3,446 (vs ₫3,610 in 2Q 2021)

First quarter 2022 earnings released: EPS: ₫2,448 (vs ₫1,975 in 1Q 2021)

No independent directors

Upcoming dividend of ₫6,000 per share

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2021 earnings released: EPS ₫3,610 (vs ₫3,975 in 2Q 2020)

First quarter 2021 earnings released: EPS ₫1,975 (vs ₫2,521 in 1Q 2020)

First Dividend Is ₫8,000 Per Share

Investor sentiment improved over the past week

New 90-day high: ₫109,700

New 90-day high: ₫87,000

New 90-day high: ₫86,000

New 90-day high: ₫84,000

Third quarter earnings released

New 90-day high: ₫75,200

New 90-day high - ₫74,000

CEO